BTI Biotechnology Institute
The Endoret® (prgf®) technology represents a new milestone in the development and use of autologous biological therapies for tissue repair and regeneration.
The set of Endoret® (prgf®) technology formulations represents a solution in terms of safety, effectiveness and reproducibility that ophthalmologists demanded in the treatment of various eye diseases as:
- Moderate to Severe Dry Eye, Persistent Epithelial Defects, Corrective Amyotrophia Surgery, burns, perforations and inflammation
First Time Exhibitor? Yes